Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma.

BMC pulmonary medicine - 29 Nov 2022

Yu Yingying, Duan Xiumei, Wang Shuai, He Hua, Lan Shijie, Guo Zhen, Wu Di

Abstract excerpt

BACKGROUND: Pulmonary sarcomatoid carcinoma (PSC) is a heterogeneous disease with poor prognosis. It is essential to understand the molecular basis of its progression in order to devise novel therapeutic strategies. The aim of this study was to identify the pathological mutations in PSC through next generation sequencing technology (NGS), and provide reference for the diagnosis and molecular targeted therapy....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Pathology, Molecular

Share to Proto-Oncogene Proteins p21(ras)

Source

Open in PubMed Open full text

Identifiers

PMID: 36447228
DOI: 10.1186/s12890-022-02248-9
PMCID: PMC9710017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma.PMID 36447228Read ↗

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinomaSemantic proximity Read ↗

Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.Semantic proximity Read ↗

Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies KRAS mutation as a biomarker of poor prognosis.Semantic proximity Read ↗

New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profilesSemantic proximity Read ↗

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.Semantic proximity Read ↗

Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma.Semantic proximity Read ↗

Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.Semantic proximity Read ↗

The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients.Semantic proximity Read ↗

KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma.Semantic proximity Read ↗

Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma.Semantic proximity Read ↗

Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma.Semantic proximity Read ↗

Genomic Landscape of Pulmonary Sarcomatoid Carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.